Evaluation and Treatment of People With Eye Diseases
Evaluation and Treatment Protocol for Potential Research Participants With Ocular Diseases
2 other identifiers
observational
2,164
1 country
1
Brief Summary
This study will evaluate and provide standard treatments for people with various eye conditions. It will provide a resource for enrollment into new research protocols throughout the Eye Institute and will allow institute specialists the opportunity to maintain their expertise and gain additional knowledge of the course of various eye disorders. The information obtained will allow for the evaluation of standard treatments and may lead to ideas for future research. People with diagnosed or undiagnosed eye disease and first-degree relatives of people with a genetic or developmental eye disease may be eligible for this study. Participants are evaluated and treated in the National Eye Institute. Blood or other tissue samples (e.g., urine, stool, hair, saliva or cheek swab) may be collected for future laboratory studies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 25, 2008
CompletedFirst Submitted
Initial submission to the registry
July 2, 2008
CompletedFirst Posted
Study publicly available on registry
July 3, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
July 12, 2017
CompletedDecember 16, 2019
July 12, 2017
July 2, 2008
December 13, 2019
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Participants will be eligible if they:
- Have either a diagnosed or undiagnosed eye disease, OR are an unaffected first-degree relative of a participant with a genetic or developmental eye disease.
- Have the ability to understand and sign an informed consent or have a parent/legal guardian to do so if they are minor children.
You may not qualify if:
- Participants will not be eligible if they:
- Are unable or unwilling to give informed consent.
- Are unwilling or unable to be followed as clinically indicated.
- Have a systemic disease that compromises the ability to provide adequate ophthalmologic examination or treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Rachel J Bishop, M.D.
National Eye Institute (NEI)
Study Design
- Study Type
- observational
- Time Perspective
- OTHER
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 2, 2008
First Posted
July 3, 2008
Study Start
June 25, 2008
Study Completion
July 12, 2017
Last Updated
December 16, 2019
Record last verified: 2017-07-12